LIQUID CHROMATOGRAPHIC GRADIENT METHOD ALLOWANCES PROVIDED BY GENERAL CHAPTER, USP CHROMATOGRAPHY <621>

Importance of the Topic

Liquid chromatographic gradient methods are central to quality control in pharmaceutical analysis. Harmonization of USP General Chapter <621> provides standardized rules for method flexibility, enabling consistent method transfer and modernization across laboratories and platforms. By adjusting critical parameters such as particle size, flow rate, gradient slope and injection volume, laboratories can implement modern LC and UHPLC systems while meeting regulatory system suitability requirements.

Objectives and Overview of the Study

This study applies the new USP <621> gradient method adjustment guidelines to an existing USP monograph for abacavir sulfate impurities. The goals include demonstrating how to mathematically transform an HPLC monograph method onto modern column dimensions and instrumentation, and verifying that the adjusted methods retain equivalent chromatographic performance and meet system suitability criteria.

Methodology and Instrumentation

The experimental workflow involved:

• Identification of the monograph method parameters for abacavir sulfate impurity separation, including a 3.9×150 mm, 5 µm C18 column and associated flow rate, gradient program and injection volume.
• Selection of modern columns—2.1 × 75 mm (2.5 µm), 2.1 × 100 mm (3.5 µm), 4.6 × 100 mm (3.5 µm), and 4.6 × 150 mm (3.5 µm)—all with L1 stationary phase substituents, meeting USP <621> L/dp ratio allowances.
• Application of USP <621> equations to adjust:
  • Flow rate to preserve linear velocity.
  • Injection volume to maintain analyte loading relative to column volume.
  • Gradient timing to conserve gradient slope relative to column volume, including an offset for instrument dwell volume differences.
• Verification of gradient calculations using Waters online calculators and Waters Preparative OBD Column Calculator.

Instrumentation Used:

• Waters Alliance iS HPLC System
• Waters Empower 3 Chromatography Data System

Main Results and Discussion

The adjusted methods on modern column formats maintained the required system suitability resolution of not less than 1.5 for the critical impurity pair. Relative retention times closely matched those from the original monograph method, particularly when using columns with identical L1 stationary phase substituents. No peak inversions or deletions were observed. The study confirmed that modern LC and UHPLC platforms can replicate monograph performance following USP <621> guidance.

Benefits and Practical Applications

• Reduced analysis time, down from longer HPLC runs to shorter UHPLC separations.
• Lower solvent and sample consumption due to smaller column volumes and injection volumes.
• Increased sample throughput, enabling more runs per hour.
• Regulatory compliance through consistent method modernization aligned with USP guidelines.

Future Trends and Possibilities

Anticipated developments include further automation of gradient adjustments via software, expansion of USP <621> flexibility ranges, and broader adoption of UHPLC in regulated environments. Emerging column chemistries and higher-pressure systems will drive faster, more efficient separations with even lower resource use.

Conclusion

The implementation of USP <621> gradient method adjustment rules successfully modernizes a monograph HPLC method for abacavir sulfate impurities onto various modern LC and UHPLC platforms. The approach preserves chromatographic quality while delivering significant efficiency gains, supporting robust quality control in pharmaceutical analysis.

Reference

• Layton C.E., Rainville P.D. Achieving Gradient Method Modernization with USP General Chapter <621>, Waters Corporation, 2023.
• USP General Chapter <621> Chromatography, Official Date: December 1, 2022.
• Abacavir Sulfate Monograph, USP, Official Date: May 1, 2020.
• Waters Preparative OBD Column Calculator and Columns Calculator 2.0, www.waters.com.